HeartX: Emerging Innovation in Atrial Fibrillation Care, Rhythm Monitoring & Electrophysiology

Take an exclusive look at emerging cardiovascular innovation from the 2025 HeartX cohort, MedAxiom and HealthTech Arkansas’s accelerator focused on supporting early-stage companies advancing cardiovascular care. CathVision highlighted its ECGenius system, which delivered high-fidelity, noise-cancelling cardiac signals to support ablation decisions. Its technology also provided real-time tissue feedback during pulsed field ablation and identified focal AFib drivers to help guide more precise interventions. FibriCheck showcased its FDA-cleared platform for remote AFib detection and monitoring, using smartphone-based assessments and AI-powered reporting to support clinical workflows, informed decision-making, and expanded access to at-home rhythm monitoring.